Inactive Provider
This provider's NPI has been deactivated on 04/29/2026. The information on this page is historical and may no longer be current.
Total Payments
$4,241
2024 Payments
$224.22
Companies
19
Transactions
191
Payment Breakdown by Category
Food & Beverage$3,881 (91.5%)
Travel$326.32 (7.7%)
Education$33.23 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,881 | 188 | 91.5% |
| Travel and Lodging | $326.32 | 1 | 7.7% |
| Education | $33.23 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $762.43 | 11 | $0 (2017) |
| Alkermes, Inc. | $718.16 | 19 | $0 (2024) |
| ABBVIE INC. | $603.21 | 27 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $378.37 | 24 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $351.67 | 36 | $0 (2022) |
| Allergan Inc. | $298.39 | 9 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $201.89 | 11 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $199.10 | 11 | $0 (2023) |
| ITI, Inc. | $168.41 | 11 | $0 (2023) |
| Lundbeck LLC | $159.09 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $224.22 | 11 | Otsuka America Pharmaceutical, Inc. ($66.77) |
| 2023 | $1,135 | 59 | Otsuka America Pharmaceutical, Inc. ($232.33) |
| 2022 | $1,058 | 50 | ABBVIE INC. ($562.51) |
| 2021 | $245.44 | 8 | Alkermes, Inc. ($186.88) |
| 2019 | $31.50 | 1 | Allergan Inc. ($31.50) |
| 2018 | $97.37 | 7 | Sunovion Pharmaceuticals Inc. ($97.37) |
| 2017 | $1,449 | 55 | Janssen Research & Development, LLC ($762.43) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: ADHD | ||||||
| 12/03/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: CNS | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: CNS | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PSYCHIATRY | ||||||
| 04/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: PSYCHIATRY | ||||||
| 01/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/29/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: Neuroscience | ||||||
| 10/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/15/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.83 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Neuropsychiatry | ||||||
| 09/09/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/31/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Stella Estruch, MD
Dr. Stella Estruch, MD is a Child & Adolescent Psychiatry healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497863252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stella Estruch, MD has received a total of $4,241 in payments from pharmaceutical and medical device companies, with $224.22 received in 2024. These payments were reported across 191 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,881).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Lauderhill, FL
- Active Since 08/29/2006
- Last Updated 12/28/2025
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1497863252
Products in Payments
- VRAYLAR (Drug) $885.62
- LYBALVI (Drug) $544.83
- REXULTI (Drug) $364.46
- LATUDA (Drug) $351.67
- CAPLYTA (Drug) $194.08
- ARISTADA (Drug) $173.33
- INVEGA SUSTENNA (Drug) $148.84
- ABILIFY MAINTENA (Drug) $132.71
- HETLIOZ (Drug) $128.08
- INGREZZA (Drug) $105.99
- VYVANSE (Drug) $82.11
- Fanapt (Drug) $71.02
- Auvelity (Drug) $63.16
- Dyanavel XR (Drug) $44.21
- SPRAVATO (Drug) $38.67
- JORNAY PM (Drug) $27.48
- TRINTELLIX (Drug) $24.34
- Xelstrym (Drug) $22.67
- UZEDY (Drug) $15.99
- NAMZARIC (Drug) $15.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.